1. HarriesAD, NyanguluDS, HargreavesNJ, KaluwaO, SalaniponiFM (2001) Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 358: 410–414.
2. StevensW, KayeS, CorrahT (2006) Antiretroviral therapy in Africa. BMJ 328: 280–282.
3. United States Congress (2001) House Committee on International Relations. The United States' War on AIDS: Hearing Before the Committee on International Relations, House of Representatives, One Hundred Seventh Congress, First Session, June 7, 2001. US Government Printing Office, 2001. pp. 28. Available: http://democrats.foreignaffairs.house.gov/archives/107/72978.pdf. Accessed 20 July 2014.
4. MillsEJ, NachegaJB, BuchanI, OrbinskiJ, AttaranA, et al. (2006) Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 296: 679–690.
5. BoulleA, SchomakerM, MayMT, HoggRS, ShepherdBE, et al. (2014) Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe or North America: a collaborative analysis of prospective studies. PLoS Med 11: e1001718.
6. UNAIDS (2014) The Gap Report. UNAIDS: Geneva, 2014. Available: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf. Accessed 20 July 2014.
7. BorJ, HerbstAJ, NewellML, BärnighausenT (2013) Increases in adult Life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 339: 961–965.
8. BraitsteinP, BrinkhofMW, DabisF, SchechterM, BoulleA, et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817–824.
9. CohenSM, Van HandelMM, BransonBM, BlairJM, HallHI, et al. (2011) Vital signs: HIV prevention through care and treatment—United States. MMWR Morb Mortal Wkly Rep 60: 1618–1623.
10. FarmerPE (2013) Chronic infectious disease and the future of health care delivery. New Engl J Med 369: 2435–2447.
11. BehforouzHL, FarmerPE, MukherjeeJS (2004) From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston. Clin Infect Dis 38: S429–S436.
12. HardonAP, AkurutD, ComoroC, EkezieC, IrundeHF, et al. (2007) Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS Care 19: 658-665.
13. BinagwahoA, NuttCT, MutabaziV, KaremaC, NsanzimanaS, et al. (2013) Shared learning in an interconnected world: innovations to advance global health equity. Globalization and Health 9: 37.
14. BinagwahoA, RatnayakeN (2009) The role of social capital in successful adherence to antiretroviral therapy in Africa. PLoS Med 6: e18.
15. GengEH, BwanaMB, KabakyengaJ, MuyindikeW, EmenyonuNI, et al. (2010) Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda. PLoS ONE 5: e14098.
16. US Centers for Disease Control and Prevention, National Center for Health Statistics, Division of Vital Statistics (2013) National Vital Statistics Report. Volume 61(4). Available: http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_04.pdf. Accessed 20 July 2014.
17. Institute for Health Metrics and Evaluation (2013) GBD 2010: GBD cause patterns visualization tool. Available: http://www.healthmetricsandevaluation.org/gbd/visualizations/gbd-cause-patterns. Accessed 20 July 2014.
18. JamisonDT, SummersLH, AlleyneG, ArrowKJ, BerkleyS, et al. (2013) Global health 2035: a world converging within a generation. Lancet 382: 1898–1955.